Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages Stemming false Single Family Member true Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:A61K36/00

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.WO/2022/139132ANTIMICROBIAL COMPOSITION AND PREPARATION METHOD THEREFOR, AND PRODUCT THEREOF
WO 30.06.2022
Int.Class A61K 33/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
14Alkali metal chlorides; Alkaline earth metal chlorides
Appl.No PCT/KR2021/013739 Applicant IHN, Dong Chul Inventor IHN, Dong Chul
The present invention relates to an antimicrobial composition and a preparation method therefor, and a product thereof, and, more specifically, to an antimicrobial composition comprising: 50-60 wt% of purified water; 1-10 wt% of a mixture comprising, in a ratio of 1:1 (50 wt% : 50 wt%), sodium chloride and calcium chloride from among chlorides; 1-2 wt% of a mixture comprising, in a ratio of 1:1 (50 wt% : 50 wt%), a Pueraria thunbergiana extract and a Platycodon grandiflorus extract from among natural extracts; 5-10 wt% of a mixture comprising, in a ratio of 1:1 (50 wt% : 50 wt%), sodium carbonate and sodium bicarbonate from among carbonates; 10-15 wt% of a mixture comprising, in a ratio of 1:1 (50 wt% : 50 wt%), lactic acid and acetic acid from among organic acids, and salts thereof; and 5-10 wt% of a mixture (undiluted solution) comprising chloric-acid-based compounds, which are inorganic acids, and thus the antimicrobial composition ensures the safety of fermentation technology, and increases absorption rate and efficacy in the body so that an excellent antibacterial or antiviral immune enhancement effect can be obtained through the synergistic effect of physiological actions.
2.WO/2022/139372METHOD FOR PREPARING AGENT FOR PREVENTION OF HAIR LOSS AND PROMOTION OF HAIR REGROWTH THROUGH FUSION FERMENTATION OF LACTIC ACID BACTERIA
WO 30.06.2022
Int.Class A61K 35/744
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
74Bacteria
741Probiotics
744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Appl.No PCT/KR2021/019416 Applicant KUNYOUNG ENC. CO., LTD. Inventor LEE, Chae Kun
The present invention is characterized by implementation of a method for preparing an agent for prevention of hair loss and promotion of hair regrowth wherein aerobic lactic acid bacteria and anaerobic lactic acid bacteria are fermented in a fusion manner to repeat a cycle of fermentation, degradation, and synthesis whereby the prevention of hair loss and the promotion of hair regrowth are achieved through the fused fermentation process of lactic acid bacteria.
3.WO/2022/139477NOVEL USE OF ARTEMISIA ANNUA EXTRACT
WO 30.06.2022
Int.Class A61K 36/282
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
282Artemisia, e.g. wormwood or sagebrush
Appl.No PCT/KR2021/019643 Applicant UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY Inventor CHOI, Jung Hye
The present invention provides a medicinal and/or culinary use of an Artemisia annua extract for treating, ameliorating and/or preventing at least one selected from among bone diseases, menopausal disorders, cardiovascular diseases, neurodegenerative diseases, and obesity. The present invention has the advantage of having little or no possibility of side effects such as cancer, and being capable of effectively treating, ameliorating and/or preventing at least one selected from among bone diseases, menopausal disorders, cardiovascular diseases, neurodegenerative diseases, and obesity.
4.WO/2022/134332USE OF ALOESIN IN PREPARATION OF PRODUCT FOR PREVENTING OR TREATING OBESITY
WO 30.06.2022
Int.Class A61K 31/352
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
Appl.No PCT/CN2021/082124 Applicant HAINAN MEDICAL UNIVERSITY Inventor WANG, Yan
The use of aloesin in the preparation of a product for preventing or treating obesity. Aloesin can inhibit lipid accumulation, increase the expression of the browning genes UCP1 and PRDM16 and the transcription factor C-EBPα, improve the expression and release of the specific factor adiponectin, and inhibit the release of the non-specific factor IL-1β, indicating that aloesin can mediate the browning of 3T3-L1 adipocytes and can be used in the preparation of a product for preventing or treating obesity.
5.WO/2022/134257USE OF COMPOUND XUESHUANTONG CAPSULE IN PREPARATION OF DRUG FOR IMPROVING MICROCIRCULATION
WO 30.06.2022
Int.Class A61K 36/808
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
80Scrophulariaceae (Figwort family)
808Scrophularia (figwort)
Appl.No PCT/CN2021/073303 Applicant SUN YAT-SEN UNIVERSITY Inventor LIU, Hong
A use of a compound xueshuantong capsule in preparation of a drug for reducing blood viscosity and resisting thrombus. Tests prove that: the effects of low-dose, medium-dose and high-dose groups of the compound xueshuantong capsule in reducing blood viscosity and resisting thrombus are significantly superior to those of a positive control group, i.e., a ligustrazine group, and the compound xueshuantong capsule has good effects of reducing blood viscosity and resisting thrombus and can significantly improve animal microcirculation conditions.
6.WO/2022/137257A NUTRACEUTICALS FORMULATION WITH AN ENHANCED ORGANOLEPTIC PROPERTIES USED FOR SCAPL AND HAIR CARE
WO 30.06.2022
Int.Class A61K 36/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Appl.No PCT/IN2021/051194 Applicant DIABLISS CONSUMER PRODUCTS PVT LTD Inventor RAMANATHAN, Vr.
The present invention relates to a nutraceuticals formulation, which could be used for scalp and hair care purposes, with an enhanced organoleptic properties. Said formulation have elements of biological origin more particularly a herbal formulation(s).
7.20220202740ORAL COMPOSITIONS COMPRISING CINNAMALDEHYDE AND USES THEREOF
US 30.06.2022
Int.Class A61K 31/11
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
11Aldehydes
Appl.No 17136932 Applicant INNOVUS PHARMACEUTICALS, INC. Inventor Bassam Damaj

Oral compositions comprising cinnamaldehyde, and methods or improving circulation and improving circulation by administering such compositions, are described. Methods and uses are describe that include the administration of an effective amount of the oral compositions to improve circulation and increasing nerve sensitization, while also resulting in improved balance, and reduced pain, numbness, and/or tingling in the hands and feet, as well as reduced restlessness, fatigue, and tiredness of the legs.

8.20220202893COMPOSITION FOR STRESS RELIEF CONTAINING FERMENTED RIPEN NONI AND CALAMANSI EXTRACT SUGAR AS ACTIVE INGREDIENTS
US 30.06.2022
Int.Class A61K 36/746
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
74Rubiaceae (Madder family)
746Morinda
Appl.No 17646467 Applicant ATOMY OROT CO., LTD. Inventor Im Joung LA

The present invention relates to a food composition for relieving stress, and specifically, to a food composition for relieving stress, which reduces secretion of the stress hormone cortisol and increases secretion of the happy hormone serotonin by containing fermented and aged noni and calamansi as active ingredients, has no side effects, and is safe for the human body. The composition of the present invention may be used as a health functional food or a pharmaceutical composition. The composition of the present invention has an excellent anti-stress effect.

9.WO/2022/137241COMPOSITIONS AND USES THEREOF FOR TREATING OR PREVENTING VIRAL INFECTIONS
WO 30.06.2022
Int.Class A61K 36/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Appl.No PCT/IL2021/051533 Applicant GILVERDI - HEALTH AND BEAUTY LTD Inventor GILAD, Vered
The present invention relates to compositions comprising one or more plant- or fungus-derived compounds and their use for treating or preventing viral respiratory infections (VRIs), such as COVID-19.
10.20220202766CENTRAL NERVOUS SYSTEM HEALTH SUPPLEMENT
US 30.06.2022
Int.Class A61K 31/352
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
Appl.No 17644069 Applicant William B. Coe Inventor William B. Coe

An orally administered composition positively mitigates the progression of central nervous system diseases such as Alzheimer's, Parkinson's and Multiple Sclerosis. The composition consists of a lipid based blood brain barrier transport medium (Base Transport Sub-Formula) to which other elements (Functional Targeting Compound) may be integrated to mediate specific chemo-neurological dysfunction. It may be administered through the mouth as droplets a spray medium or a chewable tablet.